NOBIVAC® Feline 2-FeLV | Merck Animal Health USA

Feline 2-FeLV

The only vaccine with proven two-year duration of immunity for feline leukemia.

FELINE 2-FeLV provides protection against Feline Leukemia

Feline Leukemia Virus (inactivated virus).

Only Nobivac^® FeLV vaccines are shown to be effective against persistent viremia for 2 years after vaccination.⁶⁴
Superior Efficacy demonstrated vs. multiple FeLV vaccines^{65, 66}
- Nobivac^® FeLV vaccines are the ONLY USDA-licensed vaccines that offer 2-Year Duration of Immunity (DOI) (Ideal for adherence to AAFP guidelines).^{1, 64, 67}
- The ONLY vaccine to demonstrate efficacy over the long-term in a co-mingling study mimicking real life conditions¹
Proven safety profile-99% reaction-free in ongoing surveillance involving millions of doses¹
Available in combination with other Nobivac feline vaccines to provide broader disease protection
Optimal choice for all cats under 1 year of age and healthy indoor/outdoor cats of any age

PRODUCT LABEL

Indications:

Shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline leukemia viruses. Duration of immunity is at least 2 years.

Also shown to be effective against persistent viremia in cats exposed to virulent feline leukemia virus.

FELINE 2-FELV IS A SAFE CHOICE

99.99% reaction-free in ongoing surveillance involving millions of doses¹
Two-year duration of immunity means fewer vaccinations

ADMINISTRATION AND DOSAGE

Subcutaneous or intramuscular injection
Initial 1 mL dose administered at 9 weeks of age or older
Second 1 mL dose administered 3 to 4 weeks later
Contact your veterinarian or manufacturer for more information on revaccination frequency.
Available in a 25 x 1 mL dose presentation